(40 days)
Not Found
No
The description details a programmable microprocessor controlling sequential compression based on preset pressures, which is standard automation, not AI/ML. There is no mention of learning, adaptation, or complex data analysis.
Yes
The device is used for the "treatment of lymphedema, venous insufficiencies, and other edematous conditions," indicating a therapeutic purpose.
No
The device is described as a "Sequential Compression System" for "treatment of lymphedema, venous insufficiencies, and other edematous conditions." Its function involves applying pressure to improve circulation, which is a therapeutic action, not a diagnostic one.
No
The device description clearly outlines hardware components including a pump with an air compressor, solenoid valves, printed circuit board, display, and pneumatic connections, as well as inflatable limb appliances. While software controls the operation, it is integral to a physical system.
Based on the provided information, the Wright 51 and 52 Sequential Compression System is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the treatment of lymphedema, venous insufficiencies, and other edematous conditions. This involves applying physical compression to the body.
- Device Description: The device is a pneumatic compression system that physically compresses a limb. It does not involve testing samples taken from the body (like blood, urine, or tissue) to diagnose or monitor a condition.
- Lack of IVD Characteristics: The description does not mention any components or processes related to in vitro testing, such as reagents, assays, sample handling, or analysis of biological samples.
IVD devices are specifically designed to examine specimens derived from the human body to provide information for the diagnosis, monitoring, or treatment of a disease or condition. The Wright 51 and 52 Sequential Compression System is a therapeutic device that applies external physical force.
N/A
Intended Use / Indications for Use
The Wright 51 and 52 Sequential Compression System is for treatment of lymphedema, venous insufficiencies, and other edematous conditions.
Product codes (comma separated list FDA assigned to the subject device)
JOW, 21 CFR 870.5800
Device Description
The Wright 51 and 52 Sequential Compression System consists of a sequential, segmental, intermittent, pneumatic compression pump and appropriate limb appliances. It is typically used to compress an upper or lower body extremity.
The pump consists of an enclosure that contains a small air compressor, solenoid valves, printed circuit board including a programmable microprocessor, graphic display, and associated electronic circuits and pneumatic connections. Software controls the sequential opening and closing of the solenoid valves, which are connected to five (5) external pressure ports. The pressure ports are connected to the limb appliance through a hose assembly.
The inflatable limb appliance is made of fabric and may comprise from one to five cells, with the length of the appliance dependent upon the physician's order or patients limb length. In operation, the pump fills the inflatable limb appliance with air, to prescribed, preset pressures -- each cell in sequence. This simple repetition of the sequence of compression and exhaust improves return blood circulation for the patient.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
upper or lower body extremity
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The evaluation of the device consisted of risk analysis to confirm that the device is as safe as the predicate devices and bench tests to verify conformity to performance specifications. Bench performance testing consisted of measurements of the sequence, timing, and pressure of therapy delivery along with verification of the functionality of the operator interface. In addition, electrical safety and electromagnetic compatibility testing to consensus standards was conducted.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K961797 Wright Pro-Lite, K961292 Wright Solo
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.5800 Compressible limb sleeve.
(a)
Identification. A compressible limb sleeve is a device that is used to prevent pooling of blood in a limb by inflating periodically a sleeve around the limb.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image shows the logo for Wright Therapy Products. The word "Wright" is written in a bold, sans-serif font and is surrounded by two curved arrows, one above and one below. To the right of "Wright" are the words "THERAPY PRODUCTS" in a smaller, sans-serif font. The logo is black and white.
K071040
Page lot 2
5
| §807.92 (a)(1) | MAY 22 2007 |
|---|---|
| Submitter's Name: | |
| Address: | Wright Therapy Products |
| 103-B International Drive | |
| Oakdale, PA 15071-3907 | |
| Telephone Number: | 800-631-9535 |
| Contact Person: | Carol Wright, President and CEO |
| Date of Summary Preparation: | February 28, 2007 |
| §807.92 (a)(2) | |
| Trade Name: | Wright 51 and 52 Sequential Compression System |
| Common Names: | Lymphedema pump |
| Pneumatic compression pump or device | |
| Compression pump | |
| Classification Name: | Sleeve, Limb, Compressible |
| Product Code: | JOW, 21 CFR 870.5800 |
| §807.92 (a)(3) |
| Legally Marketed Substantially Equivalent Devices: | K961797 Wright Pro-Lite |
|---|---|
| K961292 Wright Solo |
$807.92 (a)(4)
Description of Device:
The Wright 51 and 52 Sequential Compression System consists of a sequential, segmental, intermittent, pneumatic compression pump and appropriate limb appliances. It is typically used to compress an upper or lower body extremity.
The pump consists of an enclosure that contains a small air compressor, solenoid valves, printed circuit board including a programmable microprocessor, graphic display, and associated electronic circuits and pneumatic connections. Software controls the sequential opening and closing of the solenoid valves, which are connected to five (5) external pressure ports. The pressure ports are connected to the limb appliance through a hose assembly.
The inflatable limb appliance is made of fabric and may comprise from one to five cells, with the length of the appliance dependent upon the physician's order
1
KC71040
Page 2 of 2
or patients limb length. In operation, the pump fills the inflatable limb appliance with air, to prescribed, preset pressures -- each cell in sequence. This simple repetition of the sequence of compression and exhaust improves return blood circulation for the patient.
$807.92 (a)(5)
Intended Use:
The Wright 51 and 52 Sequential Compression System is for treatment of lymphedema, venous insufficiencies, and other edematous conditions.
$807.92 (a)(6)
Comparison of Technical Characteristics
The Wright 51 and 52 Sequential Compression System is comparable to the previously cleared predicate devices:
- Same intended use
- . Same operating principle
- Similar technology .
- . Same manufacturing process
In the new therapy device the pump is controlled by software in a microprocessor along with associated electronic circuits, while the predicate devices uses relay controls. The user interface of the new device is based on a touch screen and digital display, compared to analog knobs and meters in the predicate device. The new and the predicate devices use limb appliances of the same material, with the maximum number of cells increased from three to five in the new device.
§807.92 (b)(1)
Nonclinical Testing:
The evaluation of the device consisted of risk analysis to confirm that the device is as safe as the predicate devices and bench tests to verify conformity to performance specifications. Bench performance testing consisted of measurements of the sequence, timing, and pressure of therapy delivery along with verification of the functionality of the operator interface. In addition, electrical safety and electromagnetic compatibility testing to consensus standards was conducted.
8807.92 (b)(2)
Clinical Testing: None
$807.92 (b)(3)
Conclusion
Based on the above, we conclude that the Wright 51 and 52 Sequential Compression System is substantially equivalent to the legally marketed predicate device, and does not raise any new issues of safety or effectiveness.
2
Image /page/2/Picture/2 description: The image shows the seal of the U.S. Department of Health and Human Services. The seal features an abstract eagle design with three stylized lines representing the eagle's body and wings. The words "DEPARTMENT OF HEALTH AND HUMAN SERVICES. USA" are arranged in a circular pattern around the eagle. The seal is black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAY 2 2 2007
Wright Therapy Products c/o Barbara Majchrowski Senior Project Engineer 5200 Butler Pike Plymouth Meeting, PA 19426-1298
Re: K071040
Trade/Device Name: Wright 51 and 52 Sequential Compression System Regulation Number: 21 CFR 870.5800 Regulation Name: Compressible limb sleeve Regulatory Class: Class II Product Code: JOW Dated: April 11, 2007 Received: April 12, 2007
Dear Ms. Majchrowski:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 – Ms. Majchrowski
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
Duma R. Vunes
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
4. INDICATIONS FOR USE STATEMENT
510(k) Number (if known):
KO71040
Device Name: __ Wright 51 and 52 Sequential Compression System
Indications For Use:
The Wright 51 and 52 Sequential Compression System is for treatment of lymphedema, venous insufficiencies, and other edematous conditions.
Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Duna R. Ladner
(Division Sign-Off) Division of Cardiovascular Devices
510(k) Number Kozlo40